Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

VIRI Virios Therapeutics Inc

3,875

0,00 (0,00%)

29 Nov 2024 - Geschlossen

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

Virios Therapeutics (NASDAQ:VIRI)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Click Here for more Virios Therapeutics Charts.

Virios Therapeutics (NASDAQ:VIRI)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Click Here for more Virios Therapeutics Charts.

News Virios Therapeutics Inc

Form 8-K - Current report
Donnerstag 21 November 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Freitag 8 November 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 7 November 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 30 Oktober 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Donnerstag 17 Oktober 2024 (1 Monat vor) • Edgar (US Regulatory)

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Dienstag 15 Oktober 2024 (1 Monat vor) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Montag 7 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 7 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”)
Montag 7 Oktober 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Freitag 9 August 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 8 August 2024 (4 Monate vor) • Edgar (US Regulatory)

Virios Therapeutics Announces Second Quarter 2024 Financial Results
Donnerstag 8 August 2024 (4 Monate vor) • GlobeNewswire Inc.

Weitere Virios Therapeutics Inc News-Artikel

Exchange Traded Fund Csi...

AmundiMSCI Indonesia UCI...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen